Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy

Wound Repair and Regeneration

Volumn 13, Issue 4, 2005, Pages 412-421

  Gallant Behm, Corrie L ^a   Yin, Hua Q ^b   Liu, Shijie ^c   Heggers, John P ^d   Langford, E ^b   Olson, Merle E ^a   Hart, David A ^a   Burrell, Robert E ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b Nucryst Pharmaceutical Corporation   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; SULFADIAZINE SILVER; VANCOMYCIN;

ACINETOBACTER; ALCALIGENES; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS; BACTEROIDES FRAGILIS; BURKHOLDERIA CEPACIA; CANDIDA GLABRATA; CITROBACTER KOSERI; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTEROCOCCUS; ESCHERICHIA COLI; EVALUATION; HEALTH CARE PERSONNEL; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MUCOR; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; WOUND DRESSING;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL INFECTIONS; BANDAGES; MICROBIAL SENSITIVITY TESTS; MYCOSES; SILVER COMPOUNDS; WOUND INFECTION;

EID: 23044508408     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2005.130409.x     Document Type: Article

References (36)

1. Bowler P. The anaerobic and aerobic microbiology of wounds: a review. Wounds 1998;10:170-8.
2. Mertz PM, Patti JM, Marcin JJ, Marshall DA. Model for studying bacterial adherence to skin wounds. J Clin Microbiol 1987;25:1601-4.
3. Mertz PM, Ovington LG. Wound healing microbiology. Dermatol Clin 1993;11:739-47.
4. Robson MC. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg Clin N Am 1997;77:637-50.
5. Schraibman IG. The significance of beta hemolytic streptococci in chronic leg ulcers. Ann Royal Coll Surg Eng 1990;72:123-4.
6. Heggers JP, Haydon S, Ko F. Pseudomonas aeruginosa exotoxin A: its role in retardation of wound healing. J Burn Care Rehab 1992;13:512-8.
7. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003;27:341-53.
8. Tredget EE, Shankowsky HA, Groenveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998;19:531-7.
9. Grier N. Silver and its compounds. In: Block SS, editor. Disinfection, sterilization, and preservation, 3rd Ed. Philadelphia: Lea & Febiger, 1983:375-89.
10. Gupta A, Matsui K, Lo J-F, Silver S. Molecular basis for resistance to silver cations in Salmonella. Nat Med 1999;5:183-8.
11. Heggers JP, Robson MC. The emergence of silver sulphadiazine-resistant Pseudomonas aeruginosa. Burns 1978;5:184-7.
12. + and are deficient in porins. J Bacteriol 1997;179:6127-32.
13. Drlica K. The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 2003;52:11-7.
14. Spadaro JA. Antibacterial effects of silver electrodes. Annual Conference of Electrochemistry-IEEE. Eng Med Biol Society 1981:215-8.
15. Rosenkranz HS, Carr HS. The determination of the susceptibility of bacterial isolates to silver sulfadiazine. Chemotherapy 1978;24:143-5.
16. Hall RE, Bender G, Marquis RE. Inhibitory and cidal antimicrobial actions of electrically generated silver ions. J Oral Maxillofac Surg 1987;45:779-84.
17. Spacciapoli P, Buxton D, Rothstein D, Friden P. Antimicrobial activity of silver nitrate against periodontal pathogens. J Periodont Res 2001;36:108-13.
18. Jackson GG, Riff LJ. Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin. J Infect Dis 1971;124:S185-91.
19. Stratton CW, Cooksey RC. Susceptibility tests: special tests. In: Hausler WJ Jr, editor. Manual of clinical microbiology, 5th Ed. Washington: American Society for Microbiology, 1991:1153-65.
20. Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings: In vitro examination of two controlled release of silver dressings. Wounds 1998;10:179-88.
21. Wright JB, Lam K, Hansen DL, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-50.
22. Carr HS, Wlodkowski TJ, Rosenkranz HS. Silver sulfadiazine: In vitro antibacterial activity. Antimicrobial Agents Chemother 1973;4:585-7.
23. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of Acticoat antimicrobial barrier dressing. J Burn Care Rehabil 1999;20:195-200.
24. Richard JW, Spencer BA, McCoy LF, Carino E, Washington J, Edgar P, Rosenblatt J, Goodheart R, Heggers JP. Acticoat versus Silverlon: the truth. J Burns 2002;1:11-9.
25. Spadaro JA, Webster A, Becker RO. Silver polymethyl methacrylate antibacterial bone cement. Clin Orthop Rel Res 1979;143:266-70.
26. Deitch EA, Marino AA, Malakanok V, Albright JA. Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity. J Trauma 1987;27:301-4.
27. Falcone AE, Spadaro JA. Inhibitory effects of electrically activated silver material on cutaneous wound bacteria. Plast Reconstr Surg 1986;77:455-9.
28. George N, Faoagali J, Muller M. Silvazine (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates. Burns 1997;23:493-5.
29. Spadaro JA. Electrical activation of Silver bacteriostasis. In: 7th Annual Meeting of the Society for Biomaterials, Troy, NY: Trans Society Biomater, 1981;4:70.
30. Spadaro JA. Bone formation and bacterial inhibition with silver and other electrodes. Reconstr Surg Traumatol 1985;19:40-50.
31. Ricketts CR, Lowbury EJL, Lawrence JC, Hall M, Wilkins MD. Mechanism of prophylaxis by silver compounds against infection of burns. Br Med J 1970;2:444-6.
32. Spadaro JA, Chase SE, Webster DA. Bacterial inhibition by electrical activation of percutaneous silver implants. J Biomed Mater Res 1986;20:565-77.
33. Spadaro JA, Berger TJ, Barranco SD, Chapin SE, Becker RO. Antibacterial effects of silver electrodes with weak direct current. Antimicrobial Agents Chemother 1974;6:637-42.
34. Spadaro JA, Becker RO. Some specific cellular effects of electrically injected silver and gold ions. Bioelectrochem Bioenerg 1976;3:49-57.
35. Marino AA, Deitch EA, Malakanok V, Albright JA, Specian RD. Electrical augmentation of the antimicrobial activity of silver-nylon fabrics. J Biol Phys 1984;12:93-8.
36. Burrell RE. A scientific perspective on the use of topical silver preparations. Ostomy/Wound Manage 2003;49:5a(suppl):19-24.